研究生物标志物以确定COVID-19患者的严重程度和肺损伤
Alfian Nur Rosyid1, Arina Dery Puspitasari2, Wiwin Is Effendy3
1Doctoral Program of Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
Journal of infection in developing countries
|October 22, 2024
概括
这项研究验证了COVID-19严重程度和肺损伤的标记物,使用ACE2,NLR,KL-6,MMP-9和TIMP-1发现疾病严重程度和感染后肺损伤之间的相关性.
科学领域:
- 医学研究 医学研究
- 发现生物标志物的发现.
- 传染病流行病学 传染病流行病学
背景情况:
- 识别炎症和肺损伤标志物对于降低COVID-19发病率和死亡率至关重要.
- 这项研究旨在验证疾病严重程度和感染后肺损伤的标志物.
研究的目的:
- 检查COVID-19严重程度和肺损伤标记物的有效性和可靠性.
- 分析疾病严重程度和肺损伤之间的关系.
主要方法:
- 在Airlangga大学医院对76名患者的前性分析.
- 通过使用血管酶转化酶2 (ACE2) 水平和全血细胞计来评估COVID-19的严重程度.
- 用Krebs von de Lungen (KL) -6,矩阵金属蛋白酶 (MMP) -9,组织抑制剂金属蛋白酶 (TIMP) -1,以及MMP-9/TIMP-1比率进行评估的肺损伤.
- 使用了确认因素分析 (CFA) 和正典相关性.
主要成果:
- 鉴定出ACE2,中性粒细胞,淋巴细胞和NLR是COVID-19严重程度的适当标记物.
- KL-6,MMP-9和TIMP-1有效地测量了肺损伤.
- 准则相关性分析显示,疾病严重程度和肺损伤之间存在显著的相关性 (t=7.04).
结论:
- ACE2,IL-6,IL-10,中性粒细胞,淋巴细胞,白细胞和NLR足够衡量COVID-19的严重程度.
- KL-6,MMP-9和TIMP-1是肺损伤的可靠指标.
- 在COVID-19疾病严重程度和感染后肺损伤之间存在显著的相关性.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
103
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
103
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
61
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
61
Pneumonia III: Complications and Assessment
174
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
174
Statistical Methods for Analyzing Epidemiological Data
310
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
310
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K


